B7H3 CAR T cells

B7H3-targeted CAR T cells · Guangzhou Bio-gene Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for B7H3 CAR T cells, covering 2025-09-03 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults [Phase 1]